Office of Licensing & Ventures
News
Read the latest announcements coming from OLV. Click a headline for details.
Celsion Announces Issuance of U.S. Patent Covering ThermoDox(R) Technologies
April 13, 2011
New Patent Extends U.S. Intellectual Property Protection of ThermoDox(R) and Other Temperature-Sensitive Liposomal Formulations to 2021
Celsion Receives COMP Recommendation for Orphan Drug Designation in Europe for ThermoDox® to Treat Primary Liver Cancer
November 11, 2010
Cellona Therapeutics, Inc. Awarded Qualifying Therapeutic Discovery Project (QTDP) Grant for CT-10 Novel Targeted Cancer Compound
November 3, 2010
Cellona Therapeutics, Inc. and Duke Announce Exclusive Licensing Agreement and Collaboration to Develop Novel Cancer Drugs
September 14, 2010
Argos Therapeutics Presents Positive Phase 2 Data for Arcelis™ Dendritic Cell-based Immunotherapy in Advanced RCC at ASCO
June 8, 2010
-Interim Data in Combination with Sunitinib Demonstrate Positive Clinical Activity-
PhaseBio Pharmaceuticals, Inc. Raises $25 Million in Series B Funding, Initiates Collaboration with OSI Pharmaceuticals
January 7, 2010
Aerie Pharmaceuticals’ ROCK Inhibitor, AR-12286, Demonstrates Positive Results in Glaucoma Patients in a Phase 2a Study
October 22, 2009
Novel Drug has Potential to Create Significant Improvement in Function of Diseased Tissue
Centice Corporation closes on $6.1 million Series C financing
October 21, 2009
Funds to support commercialization of innovative PASS Rx® system